drugset / Trial / NCT00965055

Ezetimibe in Patients Hypo-responsive to Statins

NCT00965055

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Response to statin therapy for elevated low density lipoprotein is variable and may be influenced by cholesterol absorption. This study will evaluate whether combination therapy with atorvastatin/ezetimibe will be superior to atorvastatin alone in subjects who have less than 25% LDL reduction on starting dose statin (eg, atorvastatin 10 mg daily or simvastatin 20 mg daily).

Timeline

Start
2009-09
Primary completion
2011-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 80 mg
Subject Ezetimibe Unknown 10 mg